As leptin-treated NK-92 cells also showed a significantly less cytotoxicity against CRC cells than untreated NK-92 cells, it was discussed that a reduced expression of the activating NKp46 may be associated with an impaired NK cell response against tumor cells, thus increasing the risk to develop cancer (53). This evidence concerns the gene NCR1 and colorectal carcinoma.